Prognostic value of dipyridamole stress myocardial contrast echocardiography: comparison with single photon emission computed tomography

Dana Dawson; Sanjiv Kaul; Dawn Peters; Diana Rinkevich; Gregory Schnell; J Todd Belcik; Kevin Wei

doi:10.1016/j.echo.2009.04.034

Prognostic value of dipyridamole stress myocardial contrast echocardiography: comparison with single photon emission computed tomography

Dana Dawson, Sanjiv Kaul, Dawn Peters, Diana Rinkevich, Gregory Schnell, J Todd Belcik, Kevin Wei

Applied Medicine

Research output: Contribution to journal › Article › peer-review

38 Citations (Scopus)

Abstract

Dipyridamole stress myocardial contrast echocardiography (MCE) can be used to detect coronary artery disease (CAD). Because it measures myocardial blood flow velocity in addition to measuring myocardial blood volume, it was hypothesized that it should have greater prognostic utility than single photon-emission computed tomography (SPECT), which measures only myocardial blood volume. Because blood flow mismatch precedes wall thickening (WT) abnormalities during demand ischemia, it was also postulated that perfusion on MCE would be superior to WT abnormalities on echocardiography for this purpose.

Original language	English
Pages (from-to)	954-960
Number of pages	7
Journal	Journal of the American Society of Echocardiography
Volume	22
Issue number	8
DOIs	https://doi.org/10.1016/j.echo.2009.04.034
Publication status	Published - Aug 2009

Keywords

adult
aged
aged, 80 and over
contrast media
coronary artery disease
dipyridamole
echocardiography
exercise test
female
humans
male
middle aged
radiopharmaceuticals
reproducibility of results
sensitivity and specificity
technetium Tc 99m sestamibi
tomography, emission-computed, single-photon
vasodilator agents

Access to Document

10.1016/j.echo.2009.04.034

Cite this

@article{d7e0b8e7ded74c909776fd28870224bf,

title = "Prognostic value of dipyridamole stress myocardial contrast echocardiography: comparison with single photon emission computed tomography",

abstract = "Dipyridamole stress myocardial contrast echocardiography (MCE) can be used to detect coronary artery disease (CAD). Because it measures myocardial blood flow velocity in addition to measuring myocardial blood volume, it was hypothesized that it should have greater prognostic utility than single photon-emission computed tomography (SPECT), which measures only myocardial blood volume. Because blood flow mismatch precedes wall thickening (WT) abnormalities during demand ischemia, it was also postulated that perfusion on MCE would be superior to WT abnormalities on echocardiography for this purpose.",

keywords = "adult, aged, aged, 80 and over, contrast media, coronary artery disease, dipyridamole, echocardiography, exercise test, female, humans, male, middle aged, radiopharmaceuticals, reproducibility of results, sensitivity and specificity, technetium Tc 99m sestamibi, tomography, emission-computed, single-photon, vasodilator agents",

author = "Dana Dawson and Sanjiv Kaul and Dawn Peters and Diana Rinkevich and Gregory Schnell and Belcik, {J Todd} and Kevin Wei",

year = "2009",

month = aug,

doi = "10.1016/j.echo.2009.04.034",

language = "English",

volume = "22",

pages = "954--960",

journal = "Journal of the American Society of Echocardiography",

issn = "0894-7317",

publisher = "Mosby/Elsevier,",

number = "8",

}

TY - JOUR

T1 - Prognostic value of dipyridamole stress myocardial contrast echocardiography

T2 - comparison with single photon emission computed tomography

AU - Dawson, Dana

AU - Kaul, Sanjiv

AU - Peters, Dawn

AU - Rinkevich, Diana

AU - Schnell, Gregory

AU - Belcik, J Todd

AU - Wei, Kevin

PY - 2009/8

Y1 - 2009/8

N2 - Dipyridamole stress myocardial contrast echocardiography (MCE) can be used to detect coronary artery disease (CAD). Because it measures myocardial blood flow velocity in addition to measuring myocardial blood volume, it was hypothesized that it should have greater prognostic utility than single photon-emission computed tomography (SPECT), which measures only myocardial blood volume. Because blood flow mismatch precedes wall thickening (WT) abnormalities during demand ischemia, it was also postulated that perfusion on MCE would be superior to WT abnormalities on echocardiography for this purpose.

AB - Dipyridamole stress myocardial contrast echocardiography (MCE) can be used to detect coronary artery disease (CAD). Because it measures myocardial blood flow velocity in addition to measuring myocardial blood volume, it was hypothesized that it should have greater prognostic utility than single photon-emission computed tomography (SPECT), which measures only myocardial blood volume. Because blood flow mismatch precedes wall thickening (WT) abnormalities during demand ischemia, it was also postulated that perfusion on MCE would be superior to WT abnormalities on echocardiography for this purpose.

KW - adult

KW - aged

KW - aged, 80 and over

KW - contrast media

KW - coronary artery disease

KW - dipyridamole

KW - echocardiography

KW - exercise test

KW - female

KW - humans

KW - male

KW - middle aged

KW - radiopharmaceuticals

KW - reproducibility of results

KW - sensitivity and specificity

KW - technetium Tc 99m sestamibi

KW - tomography, emission-computed, single-photon

KW - vasodilator agents

U2 - 10.1016/j.echo.2009.04.034

DO - 10.1016/j.echo.2009.04.034

M3 - Article

C2 - 19553084

SN - 0894-7317

VL - 22

SP - 954

EP - 960

JO - Journal of the American Society of Echocardiography

JF - Journal of the American Society of Echocardiography

IS - 8

ER -

Prognostic value of dipyridamole stress myocardial contrast echocardiography: comparison with single photon emission computed tomography

Abstract

Keywords

Access to Document

Fingerprint

Cite this